BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18381576)

  • 1. Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells.
    Endo T; Ohta K; Kobayashi T
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2409-12. PubMed ID: 18381576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.
    Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S
    J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer.
    Dalle Carbonare L; Frigo A; Francia G; Davì MV; Donatelli L; Stranieri C; Brazzarola P; Zatelli MC; Menestrina F; Valenti MT
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1249-56. PubMed ID: 22511796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro.
    Califano D; Monaco C; Santelli G; Giuliano A; Veronese ML; Berlingieri MT; de Franciscis V; Berger N; Trapasso F; Santoro M; Viglietto G; Fusco A
    Cancer Res; 1998 Feb; 58(4):823-8. PubMed ID: 9485041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
    Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factor HOXA9 is Linked to the Calcification and Invasion of Papillary Thyroid Carcinoma.
    Jin Y; Kim HK; Lee J; Soh EY; Kim JH; Song I; Chung YS; Choi YJ
    Sci Rep; 2019 May; 9(1):6773. PubMed ID: 31043660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cbfa-1 (Runx-2) and osteocalcin expression by human osteoblasts in heparin osteoporosis in vitro.
    Handschin AE; Egermann M; Trentz O; Wanner GA; Kock HJ; Zünd G; Trentz OA
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):465-72. PubMed ID: 17000892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer.
    Kebebew E; Treseler PA; Duh QY; Clark OH
    Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfa-1 via reducing its ubiquitination-mediated degradation.
    Lien CY; Lee OK; Su Y
    Stem Cells; 2007 Jun; 25(6):1462-8. PubMed ID: 17379770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.
    Sancisi V; Borettini G; Maramotti S; Ragazzi M; Tamagnini I; Nicoli D; Piana S; Ciarrocchi A
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2006-15. PubMed ID: 22821892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZBTB16 induces osteogenic differentiation marker genes in dental follicle cells independent from RUNX2.
    Felthaus O; Gosau M; Morsczeck C
    J Periodontol; 2014 May; 85(5):e144-51. PubMed ID: 24359167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
    Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
    J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.
    Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R
    Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytobiocompatibility of collagen and ePTFE membranes on osteoblast-like cells in vitro.
    Friedmann A; Dehnhardt J; Kleber BM; Bernimoulin JP
    J Biomed Mater Res A; 2008 Sep; 86(4):935-41. PubMed ID: 18067190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.